Biotech and biopharmaceutical form crucial sectors for India's overall economic development and contribute strongly to the country's both health care and industrial markets. Biotech and pharmaceutical industries facilitate innovations in medicine, vaccine, and diagnosis thereby projecting India at a global pinnacle of inexpensive yet accessible medical solutions. India is one of the world's greatest generic drugs producers, along with the burgeoning biotechnology ecosystem for drug discovery and development to manufacture. By inducing foreign investments, creating crores of employment opportunities and uplifting the portfolio of exports by that nation, the biotech and biopharma companies keep contributing towards India's GDP. There is a state-of-art research and development wing in this industry, consisting of many innovative start-ups alongside established businesses in genomics, agricultural biotech and biosimilars research.

Additionally, these industries are well-integrated into India's strategy to become a significant hub for biologics and biosimilars, providing a great avenue for strong economic returns. Policies by the government that positively promote the growth of these biotech and biopharma industries include incentives toward R&D and tax exemption for the sector, all factors contributing to further growth. Beyond national benefits, India's biotech and biopharma firms play a crucial role in...